Cristina Gasparetto, MD¹, Brea Lipe, MD², Sascha A Tuchman, MD³, Natalie S. Callander, MD⁴, Suzanne Lentzsch, MD, PhD⁵, Muhamed Baljevic, MD⁶, Adriana C Rossi, MD, MSc^7*, Nizar Bahlis, MD⁸, Darrell J White, MD⁹, Christine I Chen, MD¹⁰, Heather J Sutherland, MD, PhD¹¹, Rami Kotb, MD^12*, Richard LeBlanc, MD, FRCPC¹³, Michael Sebag, MD, PhD¹⁴, Christopher P. Venner, MD¹⁵, William I Bensinger, MD^16*, Noa Biran, MD¹⁷, Heidi Sheehan^18*, Dane Van Domelen, PhD^18*, Kai Kazuharu, MD, PhD^18* and Gary J. Schiller, MD¹⁹

¹Department of Medicine, Duke University Cancer Institute, Durham, NC
²University of Rochester, Rochester, NY
³University of North Carolina, Chapel Hill, NC
⁴Carbone Cancer Center, University of Wisconsin, Madison, WI
⁵Department of Medicine, Division of Hematology/Oncology, Columbia University, New York, NY
⁶Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE
⁷Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁸Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁹Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
¹⁰Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹Vancouver General Hospital, Vancouver, BC, Canada
¹²Cancer Care Manitoba, Winnipeg, MB, Canada
¹³Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
¹⁴Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹⁵University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
¹⁶Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹⁷John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁸Karyopharm Therapeutics Inc., Newton, MA
¹⁹David Geffen School of Medicine at University of California, Los Angeles, CA

Jesus G. Berdeja, MD¹, Noopur S. Raje, MD^2*, David S. Siegel, MD³, Yi Lin, MD, PhD⁴, Larry D. Anderson Jr., MD, PhD⁵, Paula Rodriguez-Otero, MD, PhD^6*, Salomon Manier, MD, PhD⁷, Hermann Einsele, MD⁸, Michele Cavo^9*, Anna Truppel-Hartmann, MD^10*, Everton Rowe, PhD^11*, Jill Sanford, MS^11*, Julie Wang, PharmD, PhD^11*, Timothy B. Campbell, MD, PhD^11* and Sundar Jagannath, MD¹²

¹Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
²Massachusetts General Hospital, Boston, MA
³Hackensack University Medical Center, Hackensack, NJ
⁴Mayo Clinic, Rochester, MN
⁵UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
⁶Clínical Universidad de Navarra, Pamplona, Spain
⁷Service des Maladies du Sang, CHU Lille, Lille, France
⁸University Hospital Würzburg, Würzburg, Germany
⁹Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
¹⁰bluebird bio, Cambridge, MA
¹¹Bristol Myers Squibb, Princeton, NJ
¹²Mount Sinai Medical Center, New York, NY

Marco Basset, MD^1,2*, Christoph Kimmich^3*, Tobias Dittrich, MD^4,5*, Kaya Veelken, MD^2*, Hartmut Goldschmidt, MD⁶, Dirk Hose, MD⁷, Anja Seckinger, MD⁸, Anna Jauch^9*, Carsten Mueller-Tidow, MD^10*, Ute Hegenbart, MD^11* and Stefan Schönland, MD^12*

¹Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy, Italy
²Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
³Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany
⁴Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany
⁶Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁷Department of Internal Medicine V, Univ. Hosp. Heidelberg, Heidelberg, Germany
⁸Department of Internal Medicine V, Heidelberg University, Heidelberg, BW, Germany
⁹Institute for Human Genetics, Heidelberg University Hospital, Heidelberg, Germany
¹⁰Department of Medicine V, University of Heidelberg, Heidelberg, Germany
¹¹Medicine V, University of Heidelberg, Heidelberg, Germany
¹²Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

Benjamin Diamond, MD¹, Neha Korde, MD², Alexander M. Lesokhin, MD^3,4, Eric L Smith, MD, PhD⁵, Urvi A Shah, MD⁶, Sham Mailankody, MBBS^2,7, Malin Hultcrantz, MD, PhD², Hani Hassoun, MD², Sydney X. Lu, MD, PhD², Carlyn Tan, MD², Donna Massey, MSN, RN^3*, Meghan Salcedo, BSN, RN^3*, Victoria Diab, RN^2*, Kelly Werner, RN^2*, Jenna Rispoli, RN^2*, Allison Sams, NP^3*, Dennis Verducci, NP^2*, Katie Jones, NP^2*, Julia Schlossman, BA^2*, Aisara Chansakul, BS^2*, Angela Harrison, MS^2*, Amanda Kathryn Ciardiello^8*, Elizabet Tavitian, BS^2*, Tala Shekarkhand, BS^2*, Casey Piacentini, BS^2*, Even H Rustad, MD, PhD^2,9*, Venkata D Yellapantula^10*, Francesco Maura, MD^2,4, Tim J Peterson, PharmD^11*, Andriy Derkach, PhD^12*, Sean Devlin, PhD^10*, Heather J Landau, MD^13,14, Michael Scordo, MD¹⁵, David J. Chung, MD, PhD^16,17, Gunjan L. Shah, MD MS^14,18, Oscar B Lahoud, MD¹⁹, Katie Thoren^20*, Kazunori Murata^3*, Lakshmi Ramanathan, PhD^20*, Maria E. Arcila, MD^21*, Caleb Ho, MD²¹, Mikhail Roshal, MD, PhD²¹, Ahmet Dogan, MD, PhD²¹, Sergio A. Giralt, MD^3,14 and Ola Landgren, MD, PhD^2,4

¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Weill Cornell Medical College, New York, NY
⁵Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Scarsdale, NY
⁶Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Memorial Sloan Kettering Cancer Center, New York City, NY
⁹Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
¹⁰Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Scarsdale, NY
¹⁴Department of Medicine, Weill Cornell Medical College, New York, NY
¹⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
¹⁶Weill Cornell Medical College, New York
¹⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Brooklyn, NY
²⁰Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²¹Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

Evangelos Terpos, MD, PhD¹, Maria Gavriatopoulou^1*, Eirini Katodritou, MD^2*, Evdoxia Hatjiharissi, MD^3*, Ioanna Dialoupi, MD^1*, Evgenia Verrou, MD^2*, Alexandros Leonidakis, PhD^4*, Magdalini Migkou^5*, Sosana Delimpasi, MD^6*, Argiris Symeonidis, MD, PhD⁷, Efstathios Kastritis, MD^1* and Meletios A Dimopoulos⁸

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
³First Department of Internal Medicine, Division of Hematology, AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece
⁴Health Data Specialists S.A., Athens, Greece
⁵National and Kapodistrian University of Athens, Athens, Greece
⁶Hematology/Lymphomas and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁷Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Melody R Becnel, MD¹, Sandra B. Horowitz, Pharm.D.^2*, Sheeba K. Thomas, MD¹, Swami P. Iyer, MD³, Krina K. Patel, M.D.⁴, Elisabet E. Manasanch, MD¹, Donna M. Weber, MD¹, Gregory P. Kaufman, MD^1*, Hans C. Lee, MD¹ and Robert Z. Orlowski, MD, PhD⁵

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Pharmacy Clinical Programs, University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Dalia Khan^1*, Joanne Mitchell^2*, Rekha Rana^3*, Neline Kriek^4*, Amanda Unsworth^2*, Tanya Sage^5*, Michael Laffan, DM, FRCP, FRCPath⁶, Susie Shapiro, MD^7*, Anjan Thakurta^8,9*, Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD^10,11 and Jonathan Gibbins, BSc, PhD¹²

¹Blood theme Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, GBR
³University of Reading, Reading, GBR
⁴Institute For Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, GBR
⁵Institute for Cardiovascular and Metabolic Reserach, School of Biological Sciences, University of Reading, Reading, GBR
⁶Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom
⁷Oxford Haemophilia and Thrombosis Centre, Oxford University, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
⁸Bristol Myers Squibb, Princeton, NJ
⁹University of Oxford, Oxford, United Kingdom
¹⁰Oxford University Hospitals NHS Trust, Oxford, United Kingdom
¹¹Oxford University, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
¹²Inst. for Cardiovascular and Metabolic Research, School of BIological Sciences, Inst. for Cardiovascular and Metabolic Research University of Reading, Reading, United Kingdom

Giovanni Palladini, MD, PhD¹, Paolo Milani, MD, PhD², Simone Celant^3*, Valentina Summa, MD^3*, Giovanni Affronti^3*, Pier Paolo Olimpieri, PhD^3*, Sandra Petraglia, MD^3*, Andrea Foli, MD^4*, Mario Nuvolone, MD, PhD^5*, Giampaolo Merlini, MD⁶ and Pierluigi Russo, MD, PhD^3*

¹Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy
²Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
³AIFA’s Monitoring Registries Group, Italian Medicines Agency, Rome, Italy
⁴Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
⁵Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo, PAVIA, Italy
⁶Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy

Anya Yudchyts, PharmD^*, Tiffany Lin, PharmD^* and Robert Vescio, MD

Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Alessandra Brescianini, MD^1*, Renaud Desgraz, MD^1*, Ananda Plate, MSc^2*, Kathryn E. Morgan, MSc^2*, Ana Vallejo, MSc^2*, Sally Wetten, MSc^3*, Lucy DeCosta, MSc^4* and Florence Suzan, MD^1*

¹Amgen (Europe) GmbH, Rotkreuz, Switzerland
²Myeloma Patients Europe, Brussels, Belgium
³Centre for Observational Research, Amgen Ltd, Uxbridge, United Kingdom
⁴Global Biostatistical Science, Amgen Ltd., Uxbridge, United Kingdom

Ping Zhou, MD, PhD¹, Hashim Mann, MD², Xun Ma, DMD, MSc, PhD^1*, Teresa Fogaren, NP^3*, Yifei Zhang, MD³, Denis Toskic, BS^4*, Chakra P Chaulagain, MD⁵, Cindy Varga, MD, BSc⁶, Raymond L. Comenzo, MD⁶ and Amandeep Godara, MD³

¹John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
²Hematology/Oncology, Tufts Medical Center, Boston, MA
³Tufts Medical Center, Boston, MA
⁴John C Davis Myeloma and Amyloid Program, Tufts Medical Center, Revere, MA
⁵Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL
⁶Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Lauriane Clement-Filliatre, MD^1*, Lotfi Benboubker, MD^2*, Anne-Marie Stoppa^3*, Philippe Rodon, MD⁴, Kamel Laribi, MD^5*, Laure Vincent^6*, Philippe Collet^7*, Valentine Richez, MD^8*, Anne Charvet-Rumpler^9*, Hacene Zerazhi, MD^10*, Cyrille Hulin, MD^11*, Frederic Maloisel, MD, PhD^12*, Margaret Macro^13*, Lionel Karlin, MD^14*, Nathalie Texier^15*, Christos Chouaid^16* and Xavier Leleu, MD^17,18

¹CHRU Nancy, Vandoeuvre les Nancy, France
²CHU de Tours, Hôpital de Bretonneau, Tours, France
³Institut Paoli Calmettes, Marseille, France
⁴Centre Hospitalier de Périgueux, Périgueux, France
⁵Centre Hospitalier Du Mans, Le Mans, France
⁶CHU Montpellier, Montpellier, France
⁷Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France
⁸Hematology, University Nice Côte d'Azur, Nice, France
⁹CHU de Besançon, Besancon, France
¹⁰Clinical Hematology, Avignon Hospital, Avignon, France
¹¹Hôpital Haut Lévêque, CHU de Boreaux, Pessac, France
¹²Clinique Saint-Anne, Strasbourg, France
¹³Centre Hospitalier Universitaire (CHU) de Caen, Caen, France
¹⁴Centre Hospitalier Lyon Sud, Lyon, France
¹⁵Kappa Santé, PARIS, France
¹⁶CHI de Créteil, CRETEIL, France
¹⁷Hematology, Poitiers University Hospital / INSERM CIC 1402, Poitiers, France
¹⁸Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, France

Ankit Kansagra, MD^1*, Yi Lin, MD, PhD², Jesus G. Berdeja, MD³, Nina Shah, MD⁴, Albert Oriol, MD^5*, Ibrahim Yakoub-Agha⁶, Hermann Einsele, MD⁷, Alessandro Rambaldi, MD⁸, Anna Truppel-Hartmann, MD^9*, Everton Rowe, PhD^10*, Julie Wang, PharmD, PhD^10*, Amit Agarwal, MD, PhD^10*, Timothy B. Campbell, MD, PhD^10* and Sagar Lonial, MD¹¹

¹UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
²Mayo Clinic, Rochester, MN
³Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁴University of California San Francisco, San Francisco, CA
⁵Hospital Germans Trias i Pujol, Institut Josep Carreras and Institut Catala d’Oncologia, Badalona, Spain
⁶INSERM U1286, INFINITE, 59000, CHU de Lille, University of Lille, Lille, France
⁷University Hospital Würzburg, Würzburg, Germany
⁸University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁹bluebird bio, Cambridge, MA
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Emory School of Medicine, Atlanta, GA

Roberto Mina, MD^*, Alessandra Larocca, Paolo Corradini, Nicola Cascavilla, Anna Marina Liberati^*, Norbert Pescosta^*, Francesca Fazio^*, Giovannino Ciccone^*, Andrea Capra^*, Francesca Patriarca^*, Annalisa Bernardini^*, Delia Rota Scalabrini^*, Michele Cea^*, Renato Zambello^*, Anna Baraldi^*, Angelo Belotti, MD^*, Mario Boccadoro and Sara Bringhen, MD

GIMEMA, European Myeloma Network, Italy

Philippe Moreau^1*, Ajai Chari^2*, Mathias Haenel, MD^3*, Albert Oriol^4*, Paula Rodriguez-Otero, MD, PhD^5*, Helen McCarthy, PhD, FRCPath^6*, Kenshi Suzuki, MD, PhD⁷, Vania T. M. Hungria, MD, PhD⁸, Anna Sureda Balari, MD, PhD^9*, Lauriane Clement-Filliatre, MD^10*, Cyrille Hulin, MD^11*, Hila Magen, MD^12*, Shinsuke Iida, MD, PhD¹³, Vladimir Maisnar, MD^14*, Lionel Karlin, MD^15*, Luděk Pour, MD^16*, Cyrille Touzeau^1*, Shiyi Yang^17*, Michele Kosh^17*, Maria Delioukina^17*, Christoph Heuck^17* and Hartmut Goldschmidt, MD¹⁸

¹Hematology, University Hospital Hôtel-Dieu, Nantes, France
²Icahn School of Medicine at Mount Sinai, New York, NY
³Klinikum Chemnitz, Chemnitz, Germany
⁴Institut Català d'Oncologia i Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain
⁵Clínical Universidad de Navarra, Pamplona, Spain
⁶The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom
⁷Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan
⁸Clinica Medica São Germano, São Paulo, Brazil
⁹ICO-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
¹⁰Department of Hematology, CHRU Nancy Brabois, Vandoeuvre les Nancy, France
¹¹Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France
¹²Department of Hematology Chaim Sheba Medical Center, Ramat-Gan, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹³Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan
¹⁴4th Department of Medicine - Haematology, Charles University Hospital, Hradec Králové, Czech Republic
¹⁵Centre Hospitalier Lyon-Sud Hematologie (HCL), Pierre – Benite Cedex, France
¹⁶Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
¹⁷Janssen Research & Development, LLC, Spring House, PA
¹⁸Internal Medicine V and National Center for Tumor Diseases, University Clinic Heidelberg, Heidelberg, Germany

Sara Bringhen, MD¹, Luděk Pour, MD^2*, Reuben Benjamin, MBBS, FRCPath, PhD^3*, Sebastian Grosicki, MD, PhD⁴, Chang-Ki Min, M.D, Ph.D.^5*, Danielle Leao Cordeiro De Farias, MD, MSc, MBA^6,7, Alexander Vorog, MD^8*, Richard J Labotka, MD⁸, Bingxia Wang, PhD^9*, Dasha Cherepanov^8*, Lauren E. Cain, MHS, ScM, PhD^8*, Sudhakar Manne^8*, S. Vincent Rajkumar, MD^10* and Meletios A. Dimopoulos, MD¹¹

¹Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
²Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
³Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
⁴Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
⁵Department of Blood and Marrow Transplantation, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁶Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil
⁷Hospital das Clinicas, Universidade Federal de Goiás (UFG), Goiânia, Brazil
⁸Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁰Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
¹¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

H. Tilman Steinmetz, MD^1*, Moushmi Singh^2*, Joseph Milce^3*, Mohamad Haidar^3*, Achim Rieth, MD^4* and Andrea Lebioda^4*

¹Center for Hematology and Oncology, Cologne, Germany
²Amgen Ltd., Uxbridge, United Kingdom
³Kantar, Paris, France
⁴Amgen GmbH, Munich, Germany

Efstathios Kastritis, MD^1*, Ioannis Papassotiriou, PhD^2*, Foteini Theodorakakou, MD^1*, Alexandra Margeli, PhD^2*, Anastasia Barzteliotou, PhD^2*, Eleni Tsiligkeridou^1*, Amalia Andreatou^1*, Despina Fotiou, BMBS, MA^1*, Magdalini Migkou^3*, Nikolaos Kanellias, MD^1*, Ioanna Dialoupi, MD^1*, Ioannis Ntanasis-Stathopoulos, MD^1*, Panagiotis Malandrakis, MD^1*, Maria Gavriatopoulou^1*, Evangelos Terpos, MD, PhD¹ and Meletios A Dimopoulos¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Clinical Biochemistry, Aghia Sophia Children's Hospital, Athens, Greece
³National and Kapodistrian University of Athens, Athens, Greece

Michael W. Schuster, MD¹, Miguel A Canales, MD, PhD², Jason Westin, MD³, Josée M Zijlstra, MD, PhD^4*, George A Follows, MD, PhD^5*, Reem Karmali, MD, MSc⁶, Nagesh Kalakonda, MD^7*, Andre H. Goy, MD⁸, Rene-Olivier Casasnovas, MD^9*, Joost Vermaat, MD, PhD¹⁰, Eric Van Den Neste, MD^11*, Sylvain Choquet, MD^12*, Catherine Thieblemont, MD, PhD^13,14, Federica Cavallo, MD, PhD^15*, Maria de Fatima De La Cruz, MD^16*, Brian T. Hill, MD¹⁷, Herve Tilly, MD, PhD¹⁸, Shireen Kassam, MBBS, FRCPath, PhD^19*, Reda Bouabdallah, MD^20*, Ulrich Jaeger, MD²¹, Ronit Gurion, MD^22,23*, Paolo Caimi, MD²⁴, Peter Martin, FRCPC, MD, MS²⁵, Andrew Davies, MD, PhD^26*, Sonali M. Smith, MD²⁷, Graham P. Collins, MD, DPhil²⁸, Fritz Offner, MD, PhD²⁹, Gilles Salles, MD, PhD³⁰, Xiwen Ma^31*, Kelly Corona^31*, Jean-Richard Saint-Martin^31*, Anita A. Joshi^32*, Kamal Chamoun, MD^31*, Hongwei Wang, MD, PhD^32*, Jatin J. Shah, MD^31*, Sharon Shacham, PhD, MBA^31*, Michael G Kauffman, MD, PhD³¹ and Marie Maerevoet, MD^33*

¹Stony Brook University, Stony Brook, NY
²Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
⁵Addenbrooke’s Hospital, Cambridge, United Kingdom
⁶Division of Hematology, Northwestern Medical Faculty Foundation, Chicago, IL
⁷University of Liverpool, Liverpool, United Kingdom
⁸Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁹Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France
¹⁰Department of Hematology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
¹¹Cliniques universitaires Saint-Luc, Brussels, BEL
¹²Hospital Pitie Salpetriere, Paris, France
¹³Department of Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
¹⁴Diderot University, University de Paris, Paris, France
¹⁵Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
¹⁶Hospital Universitario Virgen del Rocio, Sevilla, Spain
¹⁷Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
¹⁸Centre Henri Becquerel, Rouen, France
¹⁹King's College Hospital, London, United Kingdom
²⁰Institut Paoli-Calmettes, Marseille, France
²¹Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AA, Austria
²²Tel Aviv University, Tel Aviv, Israel
²³Rabin Medical Center, Petah Tikva, Israel
²⁴University Hospitals Cleveland Medical Center, Cleveland, OH
²⁵Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
²⁶Cancer Research UK Centre/Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
²⁷Department of Oncology, University of Chicago, Chicago, IL
²⁸Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²⁹University Hospital Ghent, Gent, Belgium
³⁰Centre Hospitalier Lyon-Sud, Lyon, France
³¹Karyopharm Therapeutics, Newton, MA
³²Karyopharm Therapeutics Inc., Newton, MA
³³Institut Jules Bordet, Brussels, Belgium

Shambavi Richard, MD¹, Ajai Chari, MD², Sosana Delimpasi, MD^3*, Maryana Simonova, MD^4*, Ivan Spicka, MD, PhD^5*, Ludek Pour, MD^6*, Irina Kryachok, MD^7*, Meletios A Dimopoulos⁸, Halyna Pylypenko, MD^9*, Holger W Auner, MD, PhD¹⁰, Xavier Leleu, MD¹¹, Vadim A Doronin, MD^12*, Ganna Usenko, MD^13*, Roman Hajek, MD¹⁴, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD^15*, Tuphan Kanti Dolai, MBBS, MD, DNB, DM^16*, Dinesh Kumar Sinha, MD^17*, Christopher P. Venner, MD¹⁸, Mamta Garg, MD, FRCP, FRCPath^19*, Don A. Stevens, MD²⁰, Hang Quach, MD, FRACP, FRCPA, MBBS²¹, Sundar Jagannath, MD²², Philippe Moreau^23*, Moshe Y. Levy, MD²⁴, Ashraf Z. Badros, MD²⁵, Larry D. Anderson Jr., MD, PhD²⁶, Nizar Bahlis, MD²⁷, Thierry Facon, MD^28*, Maria-Victoria Mateos, MD, PhD²⁹, Michele Cavo^30*, Hua Chang, PhD^31*, Yosef Landesman, PhD^31*, Anita A. Joshi^32*, Yi Chai^31*, Melina Arazy, MD^32*, Jatin Shah, MD³¹, Sharon Shacham, PhD, MBA^31*, Michael G Kauffman, MD, PhD³¹, Sebastian Grosicki, MD, PhD³³ and Paul G. Richardson, MD³⁴

¹Icahn School of Medicine at Mt Sinai, Hematology/Oncology, Jersey City, NJ
²Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁴Institute of Blood Pathology & Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, MA, Ukraine
⁵Charles University and General Hospital, Prague, Czech Republic
⁶University Hospital Brno, Brno, Czech Republic
⁷Oncohematology, National Cancer Institute, Kiev, Ukraine
⁸National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁹Center of Hematology, Cherkassy Regional Oncology Center, Cherkassy, Ukraine
¹⁰Imperial College Healthcare NHS Trust, London, United Kingdom
¹¹CHU Poitiers – Hôpital la Milétrie, Poitiers, France
¹²Moscow healthcare department, City Clinical Hospital No. 40, Moscow, Russian Federation
¹³City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
¹⁴University Hospital Brno and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
¹⁵King's College Hospital NHS Foundation Trust, London, United Kingdom
¹⁶Haematology, NRS Medical College and Hospital, Kolkata, India
¹⁷Indira Gandhi Institute of Medical Sciences, Patna, India
¹⁸Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
¹⁹University Hospitals Leicester NHS Trust, Leicester, United Kingdom
²⁰Norton Cancer Institute - St Matthews Campus, Louisville, KY
²¹Melbourne Blood Specialist, East Melbourne, VIC, Australia
²²Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²³Department of Hematology, University Hospital of Nantes, Nantes, France
²⁴Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
²⁵University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²⁶UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX
²⁷University of Calgary, Calgary, AB, Canada
²⁸CHU Lille, Service des Maladies du Sang F-59000, Lille, France
²⁹Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
³⁰Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
³¹Karyopharm Therapeutics, Newton, MA
³²Karyopharm Therapeutics Inc., Newton, MA
³³Silesian Medical University, Katowice, Poland
³⁴Dana-Farber Cancer Institute, Boston, MA

Zhongjun Xia, MD, PhD¹, Su Li^2*, Xiaoqin Chen, MD, PhD^3*, Weida Wang, MD, PhD^4* and Yan Song^5*

¹Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Clinical Research, Sun Yat-Sen University Cancer Center, Guangzhou, China
³Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁴State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
⁵Link Health Group, Guangzhou, China

Olivia Perez De Acha, MD^*, Beau M Idler^*, Zachary J Walker, BS, MS^*, Peter A Forsberg, MD, Tomer M Mark, MD, MS and Daniel W. Sherbenou, MD, PhD

Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO

Manisha Bhutani, MD¹, Monika House, RN, BA^2*, Jiaxian He, MS^3*, Shebli Atrash¹, David M Foureau, PhD^4*, Barry Paul, MD, MS⁵, Reed Friend, MD¹, James T Symanowski, PhD^3*, Sarah Norek, BSN, RN^2*, Xhevahire Begic, MSPH^2*, Donna Acampora, BSN, RN^2*, Katherine K Farmer, BA^2*, Carrie Ann Syfert, BSN, RN^2*, Mauricio Pineda-Roman, MD¹, Peter Voorhees, MD¹ and Saad Z. Usmani, MD, MBBS, MBA¹

¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Hang Quach, MD¹, Simon J Harrison, MBBS MRCP (UK) PhD FRCPath (UK) FRACP², Je-Jung Lee, MD, PhD³, Nichloas Murphy, MBBS, FRACP, FRCPA^4*, Jae Hoon Lee, MD, PhD⁵, Kim Kihyun, MD^6*, Jane Estell, FRACP⁷, Noemi Horvath, MB ChB FRACP FRCPA⁸, Richard Eek, FRACP.^9*, Bradley Augustson, MBBS FRACP FRCPA^10*, Philip Campbell, MBBS¹¹, Rajeev Rajagopal, FRACP^12*, Soo-Mee Bang, MD, PhD¹³, Jeffrey SY Huang, M.D., Ph.D.^14*, Yoon Sung Soo, MD, PhD^15*, Belinda Butcher, BSci, MBiostat, PHD^16*, Brian G.M. Durie, MD¹⁷ and Wee Joo Chng, MD, PhD^18*

¹St. Vincent’s Hospital, Fitzroy, VIC, Australia
²Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
³Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanm-do, Korea, Republic of (South)
⁴Royal Hobart Hospital, Hobart, Australia
⁵Division of Hematology, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
⁶Samsung Medical Centre, Seoul, Korea, Republic of (South)
⁷Haematology Department, Concord Cancer Centre, Concord Hospital, Concord, NSW, Australia
⁸Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
⁹Border Medical Oncology, Albury, VIC, Australia
¹⁰Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
¹¹Barwon Health, University Hospital Geelong, Geelong, VIC, Australia
¹²Middlemore hospital, Auckland, New Zealand
¹³Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of (South)
¹⁴Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
¹⁵Department of Internal Medicine, Seoul National University, College of Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁶WriteSource Medical Pty Ltd, Lane Cove, Australia
¹⁷Cedars Sinai Cancer Center, Los Angeles, CA
¹⁸Department of Hematology-Oncology, National University Hospital, Singapore, Singapore

Charlotte Pawlyn, BA, PhD, MBBChir, MRCP, FRCPath^1,2, Tom Menzies^3*, Faith E. Davies⁴, Ritika Rana^5*, Jennifer Pinney^5*, Gordon Cook, MD^6*, Walter Martin Gregory, PhD^3*, Matthew W Jenner^7*, John R Jones, MD^8*, Martin F. Kaiser, MD, FRCP, FRCPath^1,2, Roger G Owen, MD^9*, Gareth Morgan, MD, PhD⁴, Graham H Jackson, MD, MA, MB BS, FRCP, FRCPath¹⁰, David Cairns, MSc, PhD^3* and Mark T Drayson, MB ChB, PhD, FRCPath^11*

¹The Royal Marsden NHS Foundation Trust, London, United Kingdom
²The Institute of Cancer Research, London, United Kingdom
³Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Perlmutter Cancer Center, New York University Langone Health, New York, NY
⁵5) Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
⁶Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁷Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
⁸Kings College Hospital NHS Foundation Trust, London, United Kingdom
⁹HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁰Department of Haematology, Newcastle University, Newcastle upon Tyne, United Kingdom
¹¹Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

Ladan Zand, MD^1*, S. Vincent Rajkumar, MD^2,3, Sanjeev Sethi, MD PhD^4*, Nelson Leung, MD^2,3 and Fernando C. Fervenza, MD PhD^5*

¹Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Minneapolis, MN
²Mayo Clinic Rochester, Division of Hematology, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester
⁵Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Monique C. Minnema¹, Angela Dispenzieri, MD², Giampaolo Merlini, MD^3*, Raymond L. Comenzo, MD⁴, Efstathios Kastritis, MD^5*, Ashutosh D. Wechalekar, MBBS, FRCP, FRCPath, DM⁶, Martha Grogan, MD^7*, Ronald Witteles, MD^8*, Frederick L. Ruberg, MD^9*, Mathew S. Maurer, MD^10*, NamPhuong Tran, MD^11*, Xiang Qin, MD, PhD^12*, Sandra Y. Vasey, MSc^12*, Brenda Tromp, MSc¹³, Brendan M. Weiss, MD^12*, Jessica Vermeulen, MD, PhD¹⁴ and Arnaud Jaccard, MD, PhD^15*

¹Department of Hematology, UMC Utrecht, Utrecht, Netherlands
²Mayo Clinic, Rochester, MN
³Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁴Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece
⁶University College London, London, GBR
⁷Cardiology, Mayo Clinic, Rochester, MN
⁸Stanford Amyloid Center, Stanford University School of Medicine, Stanford, CA
⁹Boston Medical Center, Boston University School of Medicine, Boston, MA
¹⁰Columbia University Irving Medical Center, New York, NY
¹¹Janssen Research & Development, LLC, Los Angeles, CA
¹²Janssen Research & Development, LLC, Spring House, PA
¹³Janssen Research & Development, LLC, Leiden, Netherlands
¹⁴Janssen Research & Development, LLC, Leiden, CB, Netherlands
¹⁵Centre Hospitalier Universitaire and Reference Center for AL Amyloidosis, Limoges, France

Darrell J White, MD¹, Richard LeBlanc, MD, FRCPC², Muhamed Baljevic, MD³, Nizar Bahlis, MD⁴, Suzanne Lentzsch, MD, PhD⁵, Christopher P. Venner, MD⁶, Cristina Gasparetto, MD⁷, Christine I Chen, MD⁸, Brea Lipe, MD⁹, Sascha A Tuchman, MD¹⁰, Heather J Sutherland, MD, PhD¹¹, Rami Kotb, MD^12*, Michael Sebag, MD, PhD¹³, Natalie S. Callander, MD¹⁴, William I Bensinger, MD^15*, Adriana C Rossi, MD, MSc^16*, Noa Biran, MD¹⁷, Heidi Sheehan^18*, Dane Van Domelen, PhD^18*, Tianjun Zhou, MD, PhD^18*, Kai Kazuharu, MD, PhD^18*, Jatin Shah, MD¹⁹, Sharon Shacham, PhD, MBA^19*, Michael G Kauffman, MD, PhD¹⁹ and Gary J. Schiller, MD²⁰

¹QEII Health Sciences Center and Dalhousie University, Halifax, NS, Canada
²Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
³Division of Oncology and Hematology, University of Nebraska Medical Center- Fred & Pamela Buffett Cancer Center, Omaha, NE
⁴Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
⁵Department of Medicine, Division of Hematology/Oncology, Columbia University, New York, NY
⁶Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁷Department of Medicine, Duke University Cancer Institute, Durham, NC
⁸Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹University of Rochester Medical Center, Rochester, NY
¹⁰University of North Carolina, Chapel Hill, NC
¹¹Vancouver General Hospital, Vancouver, BC, Canada
¹²Cancer Care Manitoba, Winnipeg, MB, Canada
¹³Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹⁴University of Wisconsin Hospital and Clinics, Madison, WI
¹⁵Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹⁶Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
¹⁷John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁸Karyopharm Therapeutics Inc., Newton, MA
¹⁹Karyopharm Therapeutics, Newton, MA
²⁰David Geffen School of Medicine at University of California, Los Angeles, CA

Sheeba K. Thomas, MD¹, Jatin J. Shah, MD^2*, Armando Morin, M.A.^3*, Ashley N. Morphey, M.S.N.^3*, Hans C. Lee, MD¹, Elisabet E. Manasanch, M.D.¹, Krina K. Patel, M.D.⁴, Gregory P. Kaufman, MD^1*, Swami P. Iyer, MD³, Lei Feng, MS^5*, Behrang Amini, MD, PhD^6*, Muzaffar H. Qazilbash, MD⁷, Qaiser Bashir, MD⁸, Neeraj Saini, MD⁹, Samer A. Srour, MD, MS⁸, Ralph J. Johnson, PhD^3*, Brandon N. Crumpton^3*, Mildred D. Stafford^3*, Donna M. Weber, MD¹ and Robert Z. Orlowski, MD, PhD¹⁰

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Karyopharm Therapeutics, Newton, MA
³Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Efstathios Kastritis, MD^1*, Evangelos Terpos, MD, PhD¹, Argiris Symeonidis, MD, PhD², Sosana Delimpasi, MD^3*, Michele Cavo^4*, Elena Zamagni, MD^4*, Eirini Katodritou, MD^5*, Elena Rivolti, MD^6*, Marie-Christine Kyrtsonis, MD⁷, Maria Gavriatopoulou^1*, Maria Roussou, MD^1*, Despina Fotiou, MD^1*, Evdoxia Hatjiharissi, MD^8*, Nikolaos Kanellias, MD^1*, Magdalini Migkou^9* and Meletios A Dimopoulos¹⁰

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
³Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁴Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁵Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁶Department of Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁷First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁸First Department of Internal Medicine, Division of Hematology, AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece
⁹National and Kapodistrian University of Athens, Athens, Greece
¹⁰Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Wenming Chen, MD, PhD^1*, Chengcheng Fu, MD, PhD^2*, Zhen Cai, MD, PhD^3*, Zonghai Li, MD, PhD^4*, Huijuan Wang, MD, PhD^5*, Lingzhi Yan, MD, PhD^6*, Yin Wu, MD, PhD^7*, Xiaolan Shi, MD, PhD^6*, Wen Gao, MD⁸, Shuang Yan, MD^6*, Wei Wang, MD, PhD^4*, Xiaoyan Han, MD, PhD^9*, Gaofeng Zheng, MD, PhD^10*, Yanling Wen, MD^10*, Jun Xiao, MD^4*, Huamao Wang, PhD^11* and Hong Ma, MD¹²

¹Department of Hematology, Beijing ChaoYang Hospital, Capital Medical University, Beijing, China
²Department of Hematology / Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
³Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁴CARsgen Therapeutics Co. Ltd, Shanghai, China
⁵Beijing Chao-Yang Hospital, Capital medical University, Beijing, China
⁶National Clinical Research Center for Hematologic Diseases, Suzhou, Suzhou, China
⁷Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
⁸Beijing Chaoyang Hospital, Capital medical University, BEIJING, China
⁹Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
¹⁰The First Affiliated Hospital, School of medicine, Zhejiang University, Hangzhou, China
¹¹CARsgen Therapeutics Co. LtD, Shanghai, China
¹²CARsgen Therapeutics Corporation, Bellaire, TX

Jagoda Jasielec, MD¹, Jeff Zonder, MD², Benjamin A Derman, MD¹, Donna E. Reece, MD³, Craig E. Cole, MD⁴, Jesus G. Berdeja, MD⁵, Brittany Wolfe^1*, Sarah Major^1*, Kathryn M. Tinari^1*, Andrew Stefka, MS^1*, Fabrizio Fazzi^1*, Megan Whelan^1*, Christine Gleason^1*, Amanda McIver^1*, Evangelia Andreatos^1*, Bernadette M. Libao^1*, Daniel Juergens^1*, Kent Griffith^4* and Andrzej Jakubowiak, MD, PhD¹

¹University of Chicago, Chicago, IL
²Karmanos Cancer Institute/Wayne State University, Detroit, MI
³Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴University of Michigan, Ann Arbor, MI
⁵Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN

Omar Nadeem, MD^1*, Clifton C Mo, MD^2*, Jacob P. Laubach, MD², Giada Bianchi, MD², Robert Redd^3*, Peter Barth⁴, Trevor J. Bayliss, MD^5*, Vaishali Sanchorawala, MD⁶, Leyla Shune, MD⁷, Alexandra Distaso^2*, Virginia Dalton, MS, APRN^2*, Adam S Sperling, MD, PhD⁸, Laura Amweg^2*, Mary McKenney, NP^9*, Kathleen Colson, BS, BSN, RN^10*, Ella L Millard^2*, Isabella Hou^2*, Alexandra Savell, BS^11*, Kelly Masone, BA^2*, Nikhil C. Munshi, MD¹¹, Irene M. Ghobrial, MD¹², Kenneth Anderson, MD¹³ and Paul G. Richardson, MD²

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Dana-Farber Cancer Institute, Boston
⁴Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Barrington, RI
⁵Berkshire Health Services, Pittsfield, MA
⁶Section of Hematology and Oncology, Boston Medical Center and Boston University School of Medicine, Boston, MA
⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁰Dana Farber Cancer Institute, Boston, MA
¹¹Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹²Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹³Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Barry Paul, MD, MS¹, James Symanowski, PhD^2*, Paul Osipoff^3*, Sarah Norek, BSN, RN^3*, Ami P Ndiaye, NP^1*, Jordan Robinson^1*, Shebli Atrash, MD¹, Manisha Bhutani, MD¹, Peter M. Voorhees, MD¹ and Saad Z. Usmani, MD, MBBS, MBA¹

¹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Clinical Trials, Levine Cancer Institute, Atrium Health, Charlotte, NC

Barbara Muz, PhD, MSc¹, Katherine Wasden^2*, Kinan Alhallak, BSc^3,4*, Amanda Jeske, BS^5*, Feda Azab^6*, Jennifer Sun, BSc^7*, Justin King, BS^8*, Daniel R. Kohnen, MBA^9*, Ravi Vij, MBBS^10,11 and Abdel Kareem Azab, PhD¹²

¹Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, MO
²Radiation Oncology, Washington University In St. Louis, Saint Louis, MO
³Radiation Oncology Department, Washington University in St. Louis, Saint Louis
⁴Department of Radiation Oncology; Department of Biomedical Engineering, Washington University School of Medicine, Saint Louis
⁵Department of Radiation Oncology, Washington University in St. Louis, Saint Louis, MO
⁶Radiation Oncology Department, Washington University in St. Louis, Saint Louis, MO
⁷Department of Radiation Oncology; Department of Biomedical Engineering, Washington University School of Medicine, Saint Louis, MO
⁸Division of Oncology, Washington University, Saint Louis, MO
⁹Department of Medicine, Washington University School of Medicine, Saint Louis, MO
¹⁰Section of Stem Cell Transplant and Leukemia, Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MO
¹¹Division of Oncology/Department of Medicine, Washington University School of Medicine, St Louis, MO
¹²Department of Radiation Oncology, Cancer Biology Division, Washington University In St. Louis, Saint Louis, MO

Olivia C Finney^1*, Ashish Yeri, PhD^1*, Pingping Mao, PhD^1*, Chetanya Pandya, PhD^1*, Eric Alonzo, PhD^1*, Gregory Hopkins, BS^1*, Sebastian Hymson, BS^1*, Tiffany Hu, BS^1*, Marianna Foos, MS^1*, Sneha Bhadoriya, MS^1*, Stephanie Hintzen, BS^1*, Maple Gioia, MS^1*, Alison Timm, MS^1*, Monica Massaro, MPH^1*, Ron Hause, PhD^2*, Shari Kaiser, PhD^2*, Nathan Martin, PhD^2*, Melissa Alsina, MD³, Nina Shah, MD⁴, Noopur S. Raje, MD⁵, Jesus G. Berdeja, MD⁶, Shannon Grande, PhD^1*, Hans Bitter, PhD^1*, Fabio Petrocca, MD^1*, Kevin M. Friedman, PhD^1* and Dipen Sangurdekar, PhD^1*

¹bluebird bio, Cambridge, MA
²Bristol Myers Squibb, Princeton, NJ
³Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL
⁴Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
⁵Massachusetts General Hospital Cancer Center, Mass General Hospital Cancer Center, Boston, MA
⁶Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN

Jode P Goodridge, PhD^1*, Ryan Bjordahl, PhD^2*, Sajid Mahmood, PhD^2*, John Reiser, PhD^1*, Svetlana Gaidarova, MS^2*, Robert Blum, MS^2*, Frank Cichocki, PhD^3*, Hui-yi Chu, PhD^2*, Greg Bonello, PhD^4*, Tom Lee, PhD^5*, Brian Groff^2*, Miguel Meza, BS^2*, Yu-Waye Chu, MD⁵, Bruce Walcheck, PhD^6*, Karl-Johan Malmberg, MD, PhD^7,8*, Jeffrey S. Miller, MD⁹, Armin Rehm^10*, Uta Hopken^10* and Bahram Valamehr, PhD⁵

¹Fate Therapeutics Inc., SAN DIEGO, CA
²Fate Therapeutics Inc., San Diego, CA
³Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁴Fate Therapeutics, San Diego, CA
⁵Fate Therapeutics, Inc., San Diego, CA
⁶Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN
⁷Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
⁸Center for Infectious Medicine, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
⁹Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
¹⁰Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany

Caitlin L. Costello, MD¹, Benjamin Brookhart^2*, Matthew J. Wieduwilt, MD, PhD¹, Nina Shah, MD³, Carolyn Mulroney, MD⁴ and Edward D. Ball, MD^5*

¹Moores Cancer Center, University of California, San Diego, La Jolla, CA
²Moores Cancer Center, UC San Diego, La Jolla, CA
³Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
⁴UCSD Moores Cancer Center, La Jolla, CA
⁵BMT Division, Department of Medicine, University of California, San Diego, La Jolla, CA

Guido Lancman, MD¹, Dahniel Sastow, BA^2*, Minira Aslanova, MD^2*, Erin Moshier, MS^3*, Hearn Jay Cho, MD, PhD¹, Sundar Jagannath, MD¹, Deepu Madduri, MD¹, Samir S. Parekh, MD¹, Shambavi Richard, MD^1*, Joshua Richter, M.D.^1*, Larysa Sanchez, MD¹ and Ajai Chari, MD¹

¹Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Julie Rytlewski, PhD^1*, Deepu Madduri, MD^2*, Jaymes Fuller, PhD^1*, Timothy B. Campbell, MD, PhD^1*, Afshin Mashadi-Hossein, MSc^1*, Ethan G. Thompson, PhD^1*, Yue Jiang, PhD^3*, Nathan Martin, PhD^1*, Dipen Sangurdekar, PhD^4*, Olivia Finney, PhD^4*, Hans Bitter, PhD^4*, Amit Agarwal, MD, PhD¹, Shari Kaiser, PhD^1*, Kristen Hege, MD¹ and Ronald J. Hause Jr., PhD^1*

¹Bristol Myers Squibb, Princeton, NJ
²Mount Sinai Hospital, New York, NY
³Bristol Myers Squibb, Princeton
⁴bluebird bio, Cambridge, MA

Ayano Nakamura, MD^1*, Susumu Suzuki, PhD^2,3*, Masao Seto, MD, PhD¹, Souichi Takasugi, MD^1*, Jo Kanasugi, MD^1*, Ichiro Hanamura, MD, PhD^1*, Ryuzo Ueda, MD, PhD^2* and Akiyoshi Takami, MD, PhD¹

¹Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan
²Department of Tumor Immunology, Aichi Medical University, Nagakute, Japan
³Research Creation Support Center, Aichi Medical University, Nagakute, Japan

Taxiarchis Kourelis, MD¹, Sikander Ailawadhi, MD², Dan T. Vogl, MD³, Dennis Cooper, MD⁴, Tyler D Ames, PhD^5*, Christina Y Yim, PhD^5*, Matthew R Price^5*, Jose J Jimeno, MD, PhD^5* and P. Leif Bergsagel, MD⁶

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Mayo Clinic, Jacksonville, FL
³University of Pennsylvania, Philadelphia, PA
⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁵Phosplatin Therapeutics, New York, NY
⁶Division of Hematology, Mayo Clinic, Scottsdale, AZ

Henning Schade, MD^1*, Sumit Madan, MD^2*, Eva Medvedova, MD³, Rajneesh Nath, MD^4*, Lisa Knapp^4*, Bryan Lemon, PhD^4* and Liping Laura Sun, PhD^4*

¹Colorado Blood Cancer Institute, Denver, CO
²Banner MD Anderson Cancer Center, Gilbert, AZ
³Oregon Health & Science University, Portland, OR
⁴Harpoon Therapeutics, South San Francisco, CA

Kenshi Suzuki, MD, PhD¹, Ashutosh D. Wechalekar^2*, Kihyun Kim, MD^3*, Chihiro Shimazaki, MD, PhD⁴, Jin Seok Kim, MD, PhD^5*, Takayuki Ikezoe, MD, PhD⁶, Chang-Ki Min, M.D., Ph.D.^7*, Fude Zhou^8*, Shinsuke Iida, MD, PhD⁹, Nagaaki Katoh^10*, Tomoaki Fujisaki, MD^11*, Ho-Jin Shin^12*, NamPhuong Tran, MD^13*, Xiang Qin, MD, PhD^14*, Sandra Y. Vasey, MSc^14*, Brenda Tromp, MSc¹⁵, Brendan M. Weiss, MD^14*, Jessica Vermeulen, MD, PhD^15*, Raymond L. Comenzo, MD¹⁶, Efstathios Kastritis, MD^17* and Jin Lu¹⁸

¹Japanese Red Cross Medical Center, Department of Hematology, Tokyo, Japan
²University College London and the Royal Free London NHS Foundation Trust, Division of Medicine, Faculty of Medical Sciences, London, United Kingdom
³Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁴JCHO Kyoto Kuramaguchi Medical Center, Department of Hematology, Kyoto, Japan
⁵Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
⁶Department of Hematology, Fukushima Medical School, Fukushima, Japan
⁷Seoul St. Mary’s Hospital, Seoul, Korea, Republic of (South)
⁸Peking University First Hospital, Renal Division, Department of Medicine, Beijing, China
⁹Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan
¹⁰Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Nagano, Japan
¹¹Matsuyama Red Cross Hospital, Matsuyama, Japan
¹²Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
¹³Janssen Research & Development, LLC, Los Angeles, CA
¹⁴Janssen Research & Development, LLC, Spring House, PA
¹⁵Janssen Biologics B.V., Leiden, Netherlands
¹⁶Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
¹⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁸Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing, China

Francesca Bonello^1*, Mattia D'Agostino, MD^1*, Massimo Offidani¹, Maria Teresa Petrucci¹, Anna Marina Liberati^1*, Francesca Patriarca^1*, Andrea Capra^1*, Giulia Benevolo^1*, Gianluca Gaidano¹, Gregorio Barilà^1*, Monica Galli^1*, Elena Ponticelli^1*, Nicola Cascavilla¹, Emanuele Angelucci^1*, Stelvio Ballanti^1*, Giuseppe Pietrantuono^1*, Stefano Pulini^1*, Daniele Derudas^1*, Paolo de Fabritiis^1*, Paolo Corradini¹, Concetta Conticello^1*, Michele Cavo^1*, Pieter Sonneveld, MD, PhD², Mario Boccadoro¹ and Sara Bringhen, MD¹

¹GIMEMA, European Myeloma Network, Italy
²Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Fredrik Schjesvold, MD, PhD¹, Sara Bringhen, MD², Paul G. Richardson, MD³, Aurore Perrot, MD, PhD^4*, Xavier Leleu, MD⁵, Philippe Moreau^6*, Meletios A. Dimopoulos, MD⁷, Cyrille Hulin, MD^8*, Christina Tekle^9*, Meredith Foster^10*, Elizabeth M Poole^11*, Helgi van de Velde, MD, PhD¹⁰ and Thierry Facon, MD^12*

¹Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
²Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
³Dana-Farber Cancer Institute, Boston, MA
⁴CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
⁵CHU and CIC Inserm 1402, Service D'Hématologie Et Thérapie Cellulaire, Poitiers Cedex, France
⁶University of Nantes, Nantes, France
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁸Bordeaux University Hospital, Bordeaux, France
⁹Sanofi Oncology, Cambridge, MA
¹⁰Sanofi, Cambridge, MA
¹¹Sanofi Genzyme, Global Medical Affairs, Cambridge, MA
¹²Bordeaux Hospital University Center (CHU), Lille, France

Adam D. Cohen, MD¹, Parameswaran Hari, MBBS, MD², Myo Htut, MD³, Jesus G. Berdeja, MD⁴, Deepu Madduri, MD^5*, Saad Z. Usmani, MD, MBBS, MBA⁶, Alicia J. Allred, PhD^7*, Yunsi Olyslager, MSc^8*, Arnob Banerjee, MD^7*, Jenna D. Goldberg, MD^9*, Jordan M. Schecter, MD⁹, Carolyn C. Jackson, MD, MPH^9*, Katharine S. Gries, PhD, PharmD^10*, John Fastenau, RPh, MPH, PhD^9*, William Deraedt, MSc^8*, Marlene J. Carrasco, MD, PhD, MPH^11*, Muhammad Akram, MD^11*, Farah Hossain, PharmD^11*, Sigrid Crawford, MA^12*, Ross Morrison, MPH^12*, Lynda Doward, MRes^12*, Andrzej Jakubowiak, MD, PhD¹³ and Sundar Jagannath, MD^14*

¹University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
²Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
³City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁵Mount Sinai Medical Center, New York, NY
⁶Levine Cancer Institute, Charlotte, NC
⁷Janssen R&D, Spring House, PA
⁸Janssen R&D, Beerse, Belgium
⁹Janssen R&D, Raritan, NJ
¹⁰Janssen Global Services, LLC, Raritan, NJ
¹¹Legend Biotech USA Inc., Piscataway, NJ
¹²RTI Health Solutions, Manchester, United Kingdom
¹³University of Chicago, Chicago, IL
¹⁴Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY

Enrique M. Ocio, MD, PhD¹, Aurore Perrot, MD, PhD^2*, Pierre Bories, MD^3*, Jesus F. San-Miguel, MD, PhD⁴, Igor W Blau, MD, PhD^5*, Lionel Karlin, MD^6*, Joaquin Martinez-Lopez, MD, PhD^7*, Wolfram Pönisch, MD^8*, Sara Bringhen, MD⁹, Fabio Ciceri, MD^10*, María-Victoria Mateos, MD, PhD¹¹, Paula Rodriguez-Otero^4*, Nadia Le Roux^12,13*, Yvonne Dong^14*, Thomas Fitzmaurice, PhD^15*, Corina Oprea, MD¹⁶ and Philippe Moreau^17*

¹University of Cantabria, Santander, Spain
²CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
³Toulouse University Institute of Cancer-Oncopole, Toulouse, France
⁴University of Navarra, Pamplona, Spain
⁵Charité Medical University, Berlin, Germany
⁶Hôpital Lyon sud, Hospices Civils de Lyon, Pierre-Benite, France
⁷Complutense University of Madrid, Madrid, Spain
⁸Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany
⁹University of Torino, Torino, Italy
¹⁰Vita-Salute San Raffaele University, Milan, Italy
¹¹University Hospital Salamanca, Salamanca, Spain
¹²Sanofi Oncology Development, Vitry-Sur-Seine, France
¹³Sanofi R&D, Vitry-Alfortville, France
¹⁴Sanofi, Beijing, China
¹⁵Sanofi, Cambridge, MA
¹⁶Sanofi R&D, Vitry-Alfortville, France
¹⁷University of Nantes, Nantes, France

Paul G. Richardson, MD¹, Akshanth R. Polepally, PhD^2*, Monica Motwani, PhD^2*, Yunming Mu, PhD^2*, Zeena Salman, MPH^2*, Sudhir Penugonda, MD, MPH^2* and Philippe Moreau^3*

¹Dana-Farber Cancer Institute, Boston, MA
²AbbVie Inc., North Chicago, IL
³University of Nantes, Nantes, France

Evangelos Terpos, MD, PhD¹, Kimon Stamatelopoulos, MD^2*, Nikolaos Makris, MD^2*, Ageliki Laina, MD^2*, Maria Gavriatopoulou^2*, Georgios Georgiopoulos, MD^2*, Evangelos Eleutherakis-Papaiakovou, MD^2*, Despina Fotiou, BMBS, MA^2*, Nikolaos Kanellias, MD^2*, Ioanna Dialoupi, MD^2*, Dimitris Delialis, MD^3*, Efstathios Manios, MD^2*, Magdalini Migkou^4*, Maria Roussou, MD^2*, Aristea-Maria Papanota, MD^2*, Eleni-Dimitra Papanagnou, PhD^5*, Maria Kotsopoulou, MD^2*, Ioannis P. Trougakos, PhD^5*, Meletios A Dimopoulos⁶ and Efstathios Kastritis, MD^7*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department od Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴National and Kapodistrian University of Athens, Athens, Greece
⁵Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece
⁶Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, ATHENS, Greece

Dan T. Vogl, MD¹, Yulia Nefedova, MD, PhD^2*, E. Paul Wileyto, PhD^3*, Harjeet Sembhi^3*, Inna Strakovsky, MPH, MRA^1*, Chau Nguyen^3*, Rimzim Taneja^3*, Eva Bondesson, PhD^4*, Helena Eriksson, PhD^4* and Helen Tuvesson, PhD^4*

¹University of Pennsylvania, Philadelphia, PA
²The Wistar Institute, Philadelphia, PA
³Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Active Biotech, Lund, Sweden

Sagar Lonial, MD¹, Hans C. Lee, MD², Ashraf Z. Badros, MD³, Suzanne Trudel^4*, Ajay Nooka, MD, MPH⁵, Ajai Chari^6*, Al-Ola Abdallah, MD⁷, Natalie S. Callander, MD⁸, Douglas Sborov, MD, MS⁹, Attaya Suvannasankha^10*, Katja Weisel, MD^11*, Peter Voorhees, MD¹², Joanna Opalinska¹³, Eric Zhi, PhD^13*, January Baron, MS^13*, Trisha Piontek, BSN^13*, Ira Gupta, MD¹³ and Adam D. Cohen, MD¹⁴

¹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Maryland School of Medicine, Baltimore, MD
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Winship Cancer Institute, Emory University, Atlanta, GA
⁶Icahn School of Medicine at Mount Sinai, New York, NY
⁷University of Kansas Cancer Center, Fairway, KS
⁸Carbone Cancer Center, University of Wisconsin, Madison, WI
⁹University of Utah, Huntsman Cancer Institute, Salt Lake Cty, UT
¹⁰and Roudebush VAMC, Indiana University Simon Cancer Center, Indianapolis, IN
¹¹University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
¹²Levine Cancer Institute, Atrium Health, Charlotte, NC
¹³GlaxoSmithKline, Philadelphia, PA
¹⁴University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA

Saad Z. Usmani, MD, MBBS, MBA¹, Jesus G. Berdeja, MD², Anna Truppel-Hartmann, MD^3*, Marie-Laure Casadebaig^4*, Honeylet Wortman-Vayn^5*, Suresh G. Shelat, PhD^5*, Steven Novick, MD, PhD^5* and Nina Shah, MD⁶

¹Levine Cancer Institute, Charlotte, NC
²Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
³bluebird bio, Cambridge, MA
⁴Celgene International Sàrl, a Bristol Myers Squibb Company, Boudry, Switzerland
⁵Bristol Myers Squibb, Princeton, NJ
⁶Associate Professor of Medicine, University of California San Francisco, San Francisco, CA

Rakesh Popat^1*, Ajay Nooka, MD, MPH², Keith Stockerl-Goldstein, MD^3*, Rafat Abonour, MD⁴, Ryan Ramaekers, MD^5*, Amit Khot, MD^6*, Adam Forbes, MD^7*, Cindy Lee, MD^8*, Bradley Augustson, MBBS FRACP FRCPA^9*, Andrew Spencer¹⁰, Maria-Victoria Mateos, MD, PhD¹¹, Bikramjit Chopra, PhD^12*, Rachel Rogers, MS^13*, Deborah A Smith, PharmD^14*, Jacqueline Davidge, PhD^12*, Rocio Montes de Oca, PhD^13*, Geraldine Ferron-Brady, PhD^13*, Anne Yeakey, MD^13*, Mala Talekar, MD^13*, Brandon E. Kremer, MD, PhD^13*, Ira Gupta, MD^13* and Hang Quach, MD¹⁵

¹University College London Hospitals, NHS Foundation Trust, London, United Kingdom
²Winship Cancer Institute, Emory University, Atlanta, GA
³Washington University Medical School, St. Louis, MO
⁴Queen Elizabeth Hospital, Adelaide, SA, Australia
⁵CHI Health St Francis Cancer Treatment Center, Grand Island, NE
⁶Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁷Royal Cornwall Hospital, Truro, United Kingdom
⁸Department of Haematology, Royal Adelaide Hospital & The Queen Elizabeth Hospital, Adelaide, SA, Australia
⁹Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
¹⁰Department of Clinical Haematology, Alfred Health-Monash University, Melbourne, Australia
¹¹Cancer Research Center-IBMCC (USAL-CSIC), University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain
¹²GlaxoSmithKline, Uxbridge, Middlesex, United Kingdom
¹³GlaxoSmithKline, Upper Providence, PA
¹⁴GlaxoSmithKline, Waltham, MA
¹⁵University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia

Geraldine Ferron-Brady, PhD^1*, Chetan Rathi, PhD^1*, Jon Collins, PhD^2*, Herbert Struemper, PhD^2*, Joanna Opalinska, MD^1* and Roxanne C Jewell, PhD^2*

¹GlaxoSmithKline, Collegeville, PA
²GlaxoSmithKline, Research Triangle Park, NC